COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention Friday, Sept. 23 released updates to certain COVID-19 guidance pertaining to health care providers.
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current information. The guidance updates the circumstances when source control (respirator and face mask use) and universal personal protective equipment are…
The Department of Health and Human Services (HHS) has announced that the Centers for Disease Control and Prevention (CDC) will assume responsibility for the collection of hospital COVID-19 data, beginning in mid-December 2022.
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after 48 hours to reduce the risk of missing an infection and spreading the virus to others.
The CDC released updated guidance to help people protect themselves and others if they are exposed to, sick or test positive for COVID-19.
AHA urges HHS to renew the COVID-19 public health emergency due to expire in October.
The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old
The FDA authorized state-licensed pharmacists to prescribe Paxlovid to patients as a treatment for those at high risk of severe COVID-19.
The AHA is supporting this activity by highlighting tools that aid patients and align with the new federal price transparency policy.
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for Disease Control and Prevention recommends the Pfizer and Moderna vaccines for children in this age group, Assistant Secretary for Preparedness…